888.552.6760 SCHEDULE A CONSULTATION

Temple University Hospital and Cancer Treatment Centers of America Sign Asset Purchase Agreement

March 25, 2021

(Philadelphia, PA)—March 25, 2021—Temple University Hospital (TUH) and Cancer Treatment Centers of America (CTCA) have signed an asset purchase agreement for the buildings, equipment and supplies of the current CTCA Philadelphia comprehensive cancer center campus located at 1331 E. Wyoming, Ave., in the Juniata Park section of Philadelphia.

Following the transaction and pending approval from the Pennsylvania Department of Health, the hospital will be reconfigured and operated as a nonprofit institution, consistent with Temple Health’s charitable mission. CTCA and TUH hope to close the transaction before the end of June.

“Acquisition of these resources will enable us to expand access to Temple Health’s outstanding academic medical services to the Philadelphia’s Juniata Park region and beyond. We will identify specific services we plan to offer in that location in the coming months,” said Michael A. Young, MHA, FACHE, President & CEO of Temple University Health System and Temple University Hospital.

“CTCA Philadelphia has been honored to serve cancer patients in this community,” said Maria Scenna, President of CTCA Philadelphia. “Temple Health is well-positioned to integrate these facilities into a broader continuum of care, while expanding access to their services for the local community. Our top priority will be to ensure the seamless transition of patient care as well as work with Temple Health on employee transitions. We are proud that our investment here will continue to be a valuable resource for patients and the community it serves.”

About Cancer Treatment Centers of America

Cancer Treatment Centers of America® (CTCA) is a national oncology network of hospitals and outpatient care centers offering an integrated approach that combines surgery, radiation, chemotherapy, immunotherapy and advancements in precision medicine with supportive therapies to manage side effects and enhance quality of life during treatment and into survivorship. CTCA® publishes treatment results bi-annually including patient experience, length of life, quality of life, patient safety and quality of care. CTCA also offers qualified patients a range of clinical trials that may reveal new treatment options supported by scientific and investigational research. CTCA patient satisfaction scores consistently rank among the highest for all cancer care providers in the country. Visit cancercenter.com for more information.

About Temple Health

Temple University Health System (TUHS) is a $2.2 billion academic health system dedicated to providing access to quality patient care and supporting excellence in medical education and research. The Health System includes Temple University Hospital (TUH); TUH-Episcopal Campus; TUH-Jeanes Campus; TUH-Northeastern Campus; Temple University Hospital – Fox Chase Cancer Center Outpatient Department; TUH-Northeastern Endoscopy Center; The Hospital of Fox Chase Cancer Center, together with The Institute for Cancer Research, an NCI-designated comprehensive cancer center; Fox Chase Cancer Center Medical Group, Inc., The Hospital of Fox Chase Cancer Center’s physician practice plan; Temple Transport Team, a ground and air-ambulance company; Temple Physicians, Inc., a network of community-based specialty and primary-care physician practices; and Temple Faculty Practice Plan, Inc., TUHS’s physician practice plan. TUHS is affiliated with the Lewis Katz School of Medicine at Temple University.

Temple Health refers to the health, education and research activities carried out by the affiliates of Temple University Health System (TUHS) and by the Katz School of Medicine. TUHS neither provides nor controls the provision of health care. All health care is provided by its member organizations or independent health care providers affiliated with TUHS member organizations. Each TUHS member organization is owned and operated pursuant to its governing documents.

Non-discrimination notice: It is the policy of Temple University Hospital and The Hospital of Fox Chase Cancer Center, that no one shall be excluded from or denied the benefits of or participation in the delivery of quality medical care on the basis of race, ethnicity, religion, sexual orientation, gender, gender identity/expression, disability, age, ancestry, color, national origin, physical ability, level of education, or source of payment.

Contacts:

CTCA: Abigail Obre
954-551-0519
Abigail.Obre@ctca-hope.com

Temple Health: Jeremy Walter
267-838-0398
Jeremy.Walter@tuhs.temple.edu
Follow us on Twitter @TempleMedNews

Cancer Treatment Centers of America® (CTCA) is a national oncology network of hospitals and outpatient care centers offering an integrated approach that combines surgery, radiation, chemotherapy, immunotherapy and advancements in precision medicine with supportive therapies to manage side effects and enhance quality of life during treatment and into survivorship. CTCA® publishes treatment results bi-annually including patient experience, length of life, quality of life, patient safety and quality of care. CTCA also offers qualified patients a range of clinical trials that may reveal new treatment options supported by scientific and investigational research. CTCA patient satisfaction scores consistently rank among the highest for all cancer care providers in the country. Visit cancercenter.com for more information.